joim12127-sup-0001-SupportingInformation.docWord document1077K

Data S1. Supplemental methods.

Figure S1. EFD BCG treatment reduced inflammation in Apoe−/− mice.

Figure S2. Lipid Analysis.

Figure S3. Cholesterol lipoprotein profile.

Figure S4. Antibody titers to oxLDL.

Figure S5. EFD -BCG does not interfere with vaccine protection and susceptibility to infection in vivo.

Figure S6. Increasing doses of EFD BCG do not induce side effects in OF1 Swiss mice.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.